BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22357111)

  • 21. Evidence-based consensus on opportunistic infections in inflammatory bowel disease.
    Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association
    J Dig Dis; 2018 Feb; 19(2):54-65. PubMed ID: 29330905
    [No Abstract]   [Full Text] [Related]  

  • 22. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
    Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
    Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccinating the inflammatory bowel disease patient.
    Desalermos AP; Farraye FA; Wasan SK
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):91-102. PubMed ID: 25160668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infections in inflammatory bowel disease.
    Rodríguez de Santiago E; Albillos Martínez A; López-Sanromán A
    Med Clin (Barc); 2017 May; 148(9):415-423. PubMed ID: 28233560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Terebrant and recurring herpes and zona in the course of hemopathies (treated with immunosuppressive agents)].
    Laugier P; Orusco M
    J Med Lyon; 1972 Sep; 53(232):1105-7. PubMed ID: 4344441
    [No Abstract]   [Full Text] [Related]  

  • 26. [Viral infection of herpes simplex, Epstein-Barr, varicela zoster, human papilloma, cytomegalovirus, or adenovirus are not related to sinonasal adenocarcinomas].
    Pérez Escuredo J; Llorente JL; Melón S; de Oña M; García Martínez J; Alvarez Marcos C; Hermsen M
    Acta Otorrinolaringol Esp; 2007; 58(7):311-5. PubMed ID: 17683698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.
    Subramaniam K; D'Rozario J; Pavli P
    J Gastroenterol Hepatol; 2013 Jan; 28(1):24-30. PubMed ID: 23094824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virus infections after transplantation in man. Brief review.
    Ho M
    Arch Virol; 1977; 55(1-2):1-24. PubMed ID: 200197
    [No Abstract]   [Full Text] [Related]  

  • 29. Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases.
    Beaugerie L; Rahier JF; Kirchgesner J
    Clin Gastroenterol Hepatol; 2020 May; 18(6):1324-1335.e2. PubMed ID: 32059920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis.
    Viget N; Vernier-Massouille G; Salmon-Ceron D; Yazdanpanah Y; Colombel JF
    Gut; 2008 Apr; 57(4):549-58. PubMed ID: 18178610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral infections and their management in patients with chronic lymphocytic leukemia.
    Melchardt T; Weiss L; Greil R; Egle A
    Leuk Lymphoma; 2013 Aug; 54(8):1602-13. PubMed ID: 23206225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine.
    Seksik P; Cosnes J; Sokol H; Nion-Larmurier I; Gendre JP; Beaugerie L
    Aliment Pharmacol Ther; 2009 May; 29(10):1106-13. PubMed ID: 19222411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Herpesvirus infections in dermatology].
    Honda M
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():95-8. PubMed ID: 16615448
    [No Abstract]   [Full Text] [Related]  

  • 34. Latent viral infections in young patients with inflammatory diseases treated with biological agents: prevalence of JC virus genotype 2.
    Comar M; Delbue S; Lepore L; Martelossi S; Radillo O; Ronfani L; D'Agaro P; Ferrante P
    J Med Virol; 2013 Apr; 85(4):716-22. PubMed ID: 23364870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral pneumonia in the immunocompromised patient.
    Shanley JD; Jordan MC
    Semin Respir Infect; 1986 Sep; 1(3):193-201. PubMed ID: 2825314
    [No Abstract]   [Full Text] [Related]  

  • 36. IBD: incidence of HSV and HPV with azathioprine.
    Cottone M; Renna S
    Nat Rev Gastroenterol Hepatol; 2009 Aug; 6(8):444-5. PubMed ID: 19654597
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence and association of human papillomavirus 16, Epstein-Barr virus, herpes simplex virus-1 and cytomegalovirus infection with human esophageal carcinoma: a case-control study.
    Zhang DH; Zhang QY; Hong CQ; Chen JY; Shen ZY; Zhu Y
    Oncol Rep; 2011 Jun; 25(6):1731-8. PubMed ID: 21455581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?
    Leung Y; Hanauer SB
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S202-8. PubMed ID: 20117343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients.
    Carratalà J; Montejo M; Pérez-Romero P
    Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():63-9. PubMed ID: 22542037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inflammatory bowel diseases and lymphoma].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Feb; 82(2):185-9. PubMed ID: 15185593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.